Plasma-based COVID-19 treatments in low- and middle-income nations pose a high risk of an HIV epidemic

Convalescent plasma therapy holds promise as a transient treatment for COVID-19. Yet, blood products are important sources of HIV infection in low- and middle-income nations. Great care must be taken to prevent plasma therapy from fueling HIV epidemics in the developing world.

Detalles Bibliográficos
Autores principales: Ferreira, Leonardo M. R., Mostajo-Radji, Mohammed A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Comment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338534/
https://www.ncbi.nlm.nih.gov/pubmed/32655899
http://dx.doi.org/10.1038/s41541-020-0209-2
_version_ 1783554699900747776
author Ferreira, Leonardo M. R.
Mostajo-Radji, Mohammed A.
author_facet Ferreira, Leonardo M. R.
Mostajo-Radji, Mohammed A.
author_sort Ferreira, Leonardo M. R.
collection PubMed
description Convalescent plasma therapy holds promise as a transient treatment for COVID-19. Yet, blood products are important sources of HIV infection in low- and middle-income nations. Great care must be taken to prevent plasma therapy from fueling HIV epidemics in the developing world.
format Online
Article
Text
id pubmed-7338534
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-73385342020-07-09 Plasma-based COVID-19 treatments in low- and middle-income nations pose a high risk of an HIV epidemic Ferreira, Leonardo M. R. Mostajo-Radji, Mohammed A. NPJ Vaccines Comment Convalescent plasma therapy holds promise as a transient treatment for COVID-19. Yet, blood products are important sources of HIV infection in low- and middle-income nations. Great care must be taken to prevent plasma therapy from fueling HIV epidemics in the developing world. Nature Publishing Group UK 2020-07-06 /pmc/articles/PMC7338534/ /pubmed/32655899 http://dx.doi.org/10.1038/s41541-020-0209-2 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Comment
Ferreira, Leonardo M. R.
Mostajo-Radji, Mohammed A.
Plasma-based COVID-19 treatments in low- and middle-income nations pose a high risk of an HIV epidemic
title Plasma-based COVID-19 treatments in low- and middle-income nations pose a high risk of an HIV epidemic
title_full Plasma-based COVID-19 treatments in low- and middle-income nations pose a high risk of an HIV epidemic
title_fullStr Plasma-based COVID-19 treatments in low- and middle-income nations pose a high risk of an HIV epidemic
title_full_unstemmed Plasma-based COVID-19 treatments in low- and middle-income nations pose a high risk of an HIV epidemic
title_short Plasma-based COVID-19 treatments in low- and middle-income nations pose a high risk of an HIV epidemic
title_sort plasma-based covid-19 treatments in low- and middle-income nations pose a high risk of an hiv epidemic
topic Comment
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338534/
https://www.ncbi.nlm.nih.gov/pubmed/32655899
http://dx.doi.org/10.1038/s41541-020-0209-2
work_keys_str_mv AT ferreiraleonardomr plasmabasedcovid19treatmentsinlowandmiddleincomenationsposeahighriskofanhivepidemic
AT mostajoradjimohammeda plasmabasedcovid19treatmentsinlowandmiddleincomenationsposeahighriskofanhivepidemic

Ejemplares similares